{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:37:44Z","timestamp":1777300664679,"version":"3.51.4"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T00:00:00Z","timestamp":1761609600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473331"],"award-info":[{"award-number":["82473331"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Suqian Sci&Tech Program","award":["KY202301"],"award-info":[{"award-number":["KY202301"]}]},{"name":"Jiangsu High-level Hospital Pairing Assistance Research Initiative","award":["JDBFSQ202511"],"award-info":[{"award-number":["JDBFSQ202511"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Urol Nephrol"],"DOI":"10.1007\/s11255-025-04873-9","type":"journal-article","created":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T19:20:04Z","timestamp":1761679204000},"page":"1681-1689","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bladder-sparing therapy for high-tumor-burden non-muscle invasive bladder cancer: outcomes from high-tumor-burden NMIBC program"],"prefix":"10.1007","volume":"58","author":[{"given":"Tianxiao","family":"Hong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chaoran","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haonan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuejian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangxiang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaosong","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengchao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,10,28]]},"reference":[{"key":"4873_CR1","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo N, Afferi L, Moschini M et al (2022) Epidemiology, screening, and prevention of bladder cancer. Eur Urol Oncol 5:628\u2013639. https:\/\/doi.org\/10.1016\/j.euo.2022.10.003","journal-title":"Eur Urol Oncol"},{"key":"4873_CR2","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1159\/000489083","volume":"11","author":"H Kano","year":"2018","unstructured":"Kano H, Miwa S, Koshida K, Kawai K (2018) Successful treatment of a large superficial bladder cancer with neoadjuvant arterial infusion chemotherapy: a case report. Case Rep Oncol 11:383\u2013387. https:\/\/doi.org\/10.1159\/000489083","journal-title":"Case Rep Oncol"},{"key":"4873_CR3","doi-asserted-by":"publisher","first-page":"788568","DOI":"10.3389\/fonc.2022.788568","volume":"12","author":"J Fan","year":"2022","unstructured":"Fan J, Zhang X, Fan J et al (2022) Risk stratification for the rate and location of residual bladder tumor for the decision of re-transurethral resection of bladder tumor. Front Oncol 12:788568. https:\/\/doi.org\/10.3389\/fonc.2022.788568","journal-title":"Front Oncol"},{"key":"4873_CR4","doi-asserted-by":"publisher","first-page":"338.e19","DOI":"10.1016\/j.urolonc.2015.05.011","volume":"33","author":"RS Matulewicz","year":"2015","unstructured":"Matulewicz RS, Sharma V, McGuire BB et al (2015) The effect of surgical duration of transurethral resection of bladder tumors on postoperative complications: an analysis of ACS NSQIP data. Urol Oncol 33:338.e19-338.e24. https:\/\/doi.org\/10.1016\/j.urolonc.2015.05.011","journal-title":"Urol Oncol"},{"key":"4873_CR5","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1272\/jnms.77.190","volume":"77","author":"T Hamasaki","year":"2010","unstructured":"Hamasaki T, Suzuki Y, Tomita Y et al (2010) Efficacy of transurethral resection of the bladder tumor (TUR-BT) for huge bladder cancer. J Nippon Med Sch 77:190\u2013194","journal-title":"J Nippon Med Sch"},{"key":"4873_CR6","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1016\/j.euf.2023.05.002","volume":"9","author":"S Katsimperis","year":"2023","unstructured":"Katsimperis S, Tzelves L, Tandogdu Z et al (2023) Complications after radical cystectomy: a systematic review and meta-analysis of randomized controlled trials with a meta-regression analysis. Eur Urol Focus 9:920\u2013929. https:\/\/doi.org\/10.1016\/j.euf.2023.05.002","journal-title":"Eur Urol Focus"},{"key":"4873_CR7","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1038\/nrurol.2011.147","volume":"8","author":"RE Hautmann","year":"2011","unstructured":"Hautmann RE, Hautmann SH, Hautmann O (2011) Complications associated with urinary diversion. Nat Rev Urol 8:667\u2013677. https:\/\/doi.org\/10.1038\/nrurol.2011.147","journal-title":"Nat Rev Urol"},{"key":"4873_CR8","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1016\/j.euo.2023.07.012","volume":"6","author":"R Contieri","year":"2023","unstructured":"Contieri R, Hensley PJ, Tan WS et al (2023) Oncological outcomes for patients with European association of urology very high-risk non\u2013muscle-invasive bladder cancer treated with Bacillus Calmette-Gu\u00e9rin or early radical cystectomy. Eur Urol Oncol 6:590\u2013596. https:\/\/doi.org\/10.1016\/j.euo.2023.07.012","journal-title":"Eur Urol Oncol"},{"key":"4873_CR9","doi-asserted-by":"publisher","first-page":"e0230417","DOI":"10.1371\/journal.pone.0230417","volume":"15","author":"ME Rezaee","year":"2020","unstructured":"Rezaee ME, Lynch KE, Li Z et al (2020) The impact of low- versus high-intensity surveillance cystoscopy on surgical care and cancer outcomes in patients with high-risk non-muscle-invasive bladder cancer (NMIBC). PLoS ONE 15:e0230417. https:\/\/doi.org\/10.1371\/journal.pone.0230417","journal-title":"PLoS ONE"},{"key":"4873_CR10","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.euo.2022.11.005","volume":"6","author":"T Muilwijk","year":"2023","unstructured":"Muilwijk T, Akand M, Raskin Y et al (2023) Quality control indicators for transurethral resection of bladder tumor: results from an embedded Belgian multicenter prospective registry. Eur Urol Oncol 6:422\u2013430. https:\/\/doi.org\/10.1016\/j.euo.2022.11.005","journal-title":"Eur Urol Oncol"},{"key":"4873_CR11","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.juro.2013.08.022","volume":"191","author":"JP Sfakianos","year":"2014","unstructured":"Sfakianos JP, Kim PH, Hakimi AA, Herr HW (2014) The effect of restaging transurethral resection on recurrence and progression rates in patients with nonmuscle invasive bladder cancer treated with intravesical bacillus Calmette-Gu\u00e9rin. J Urol 191:341\u2013345. https:\/\/doi.org\/10.1016\/j.juro.2013.08.022","journal-title":"J Urol"},{"key":"4873_CR12","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1097\/01.ju.0000181799.81119.fc","volume":"174","author":"HW Herr","year":"2005","unstructured":"Herr HW (2005) Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174:2134\u20132137","journal-title":"J Urol"},{"key":"4873_CR13","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s10147-016-1048-z","volume":"22","author":"N Kamiya","year":"2017","unstructured":"Kamiya N, Suzuki H, Suyama T et al (2017) Clinical outcomes of second transurethral resection in non-muscle invasive high-grade bladder cancer: a retrospective, multi-institutional, collaborative study. Int J Clin Oncol 22:353\u2013358. https:\/\/doi.org\/10.1007\/s10147-016-1048-z","journal-title":"Int J Clin Oncol"},{"key":"4873_CR14","doi-asserted-by":"publisher","first-page":"152","DOI":"10.22037\/uj.v0i0.4670","volume":"16","author":"M Ayati","year":"2019","unstructured":"Ayati M, Amini E, Shahrokhi Damavand R et al (2019) Second transurethral resection of bladder tumor: is it necessary in all T1 and\/or high-grade tumors? Urol J 16:152\u2013156. https:\/\/doi.org\/10.22037\/uj.v0i0.4670","journal-title":"Urol J"},{"key":"4873_CR15","doi-asserted-by":"publisher","first-page":"843","DOI":"10.1016\/j.eururo.2009.05.047","volume":"57","author":"P Mariappan","year":"2010","unstructured":"Mariappan P, Zachou A, Grigor KM (2010) Detrusor muscle in the first, apparently complete transurethral resection of bladder tumour specimen is a surrogate marker of resection quality, predicts risk of early recurrence, and is dependent on operator experience. Eur Urol 57:843\u2013849. https:\/\/doi.org\/10.1016\/j.eururo.2009.05.047","journal-title":"Eur Urol"},{"key":"4873_CR16","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1177\/1357633X17727773","volume":"24","author":"S Dekalo","year":"2018","unstructured":"Dekalo S, Matzkin H, Mabjeesh NJ (2018) Can urologists accurately stage and grade urothelial bladder cancer by assessing endoscopic photographs? J Telemed Telecare 24:603\u2013607. https:\/\/doi.org\/10.1177\/1357633X17727773","journal-title":"J Telemed Telecare"},{"key":"4873_CR17","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.urology.2017.08.007","volume":"109","author":"P Mariappan","year":"2017","unstructured":"Mariappan P, Lavin V, Phua CQ et al (2017) Predicting grade and stage at cystoscopy in newly presenting bladder cancers-a prospective double-blind clinical study. Urology 109:134\u2013139. https:\/\/doi.org\/10.1016\/j.urology.2017.08.007","journal-title":"Urology"},{"key":"4873_CR18","doi-asserted-by":"publisher","DOI":"10.1016\/j.urolonc.2023.08.004","author":"T Yanagisawa","year":"2023","unstructured":"Yanagisawa T, Sato S, Hayashida Y et al (2023) Clinical impact of detrusor muscle in en bloc resection for T1 bladder cancer. Urol Oncol. https:\/\/doi.org\/10.1016\/j.urolonc.2023.08.004","journal-title":"Urol Oncol"},{"key":"4873_CR19","doi-asserted-by":"publisher","first-page":"1324","DOI":"10.1016\/j.euf.2020.08.007","volume":"7","author":"R Mastroianni","year":"2021","unstructured":"Mastroianni R, Brassetti A, Krajewski W et al (2021) Assessing the impact of the absence of detrusor muscle in Ta low-grade urothelial carcinoma of the bladder on recurrence-free survival. Eur Urol Focus 7:1324\u20131331. https:\/\/doi.org\/10.1016\/j.euf.2020.08.007","journal-title":"Eur Urol Focus"},{"key":"4873_CR20","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1016\/j.euo.2023.07.010","volume":"6","author":"D D\u2019Andrea","year":"2023","unstructured":"D\u2019Andrea D, Soria F, Hurle R et al (2023) En bloc versus conventional resection of primary bladder tumor (eBLOC): a prospective, multicenter, open-label, phase 3 randomized controlled trial. Eur Urol Oncol 6:508\u2013515. https:\/\/doi.org\/10.1016\/j.euo.2023.07.010","journal-title":"Eur Urol Oncol"},{"key":"4873_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2024.04.015","author":"J Yuen-Chun Teoh","year":"2024","unstructured":"Yuen-Chun Teoh J, Cheng C-H, Tsang C-F et al (2024) Transurethral en bloc resection versus standard resection of bladder tumour: a randomised, multicentre, phase 3 trial. Eur Urol. https:\/\/doi.org\/10.1016\/j.eururo.2024.04.015","journal-title":"Eur Urol"},{"key":"4873_CR22","doi-asserted-by":"publisher","DOI":"10.1111\/bju.16543","author":"JP Struck","year":"2024","unstructured":"Struck JP, Moharam N, Leitenberger A et al (2024) An international multicentre randomised controlled trial of en bloc resection of bladder tumour vs conventional transurethral resection of bladder tumour: first results of the en bloc resection of urothelium carcinoma of the bladder (EBRUC) II trial. BJU Int. https:\/\/doi.org\/10.1111\/bju.16543","journal-title":"BJU Int"},{"key":"4873_CR23","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1038\/nrurol.2017.16","volume":"14","author":"AM Kamat","year":"2017","unstructured":"Kamat AM, Colombel M, Sundi D et al (2017) BCG-unresponsive non-muscle-invasive bladder cancer: recommendations from the IBCG. Nat Rev Urol 14:244\u2013255. https:\/\/doi.org\/10.1038\/nrurol.2017.16","journal-title":"Nat Rev Urol"},{"key":"4873_CR24","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1016\/j.eururo.2015.02.003","volume":"68","author":"DP Nguyen","year":"2015","unstructured":"Nguyen DP, Al Hussein Al Awamlh B, Wu X et al (2015) Recurrence patterns after open and robot-assisted radical cystectomy for bladder cancer. Eur Urol 68:399\u2013405. https:\/\/doi.org\/10.1016\/j.eururo.2015.02.003","journal-title":"Eur Urol"},{"key":"4873_CR25","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/j.euros.2022.02.011","volume":"39","author":"NC Grossmann","year":"2022","unstructured":"Grossmann NC, Rajwa P, Quhal F et al (2022) Comparative outcomes of primary versus recurrent high-risk non-muscle-invasive and primary versus secondary muscle-invasive bladder cancer after radical cystectomy: results from a retrospective multicenter study. Eur Urol Open Sci 39:14\u201321. https:\/\/doi.org\/10.1016\/j.euros.2022.02.011","journal-title":"Eur Urol Open Sci"}],"container-title":["International Urology and Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04873-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11255-025-04873-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11255-025-04873-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T13:42:11Z","timestamp":1777297331000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11255-025-04873-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,28]]},"references-count":25,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5]]}},"alternative-id":["4873"],"URL":"https:\/\/doi.org\/10.1007\/s11255-025-04873-9","relation":{},"ISSN":["1573-2584"],"issn-type":[{"value":"1573-2584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,28]]},"assertion":[{"value":"9 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that there are no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki and was approved by the ethics committee of the First Affiliated Hospital with Nanjing Medical University (2025-SR-305). The committee waived the requirement for written informed consent due to the retrospective nature of the study; however, verbally informed consent was obtained from all participants.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}